Ardent Health Partners, LLC (ARDT) — Analyst outlook / Analyst consensus target is. Based on 12 analyst ratings, the consensus is bullish — 8 Buy, 3 Hold, 1 Sell.
The consensus price target is $14.14 (low: $12.00, high: $19.00), representing an upside of 50.1% from the current price $9.42.
Analysts estimate Earnings Per Share (EPS) of $1.21 and revenue of $5.84B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $1.59 vs est $1.21 (beat +31.1%). 2025: actual $0.96 vs est $1.05 (missed -8.4%). Analyst accuracy: 84%.
ARDT Stock — 12-Month Price Forecast
$14.14
▲ +50.11% Upside
Average Price Target
Based on 12 Wall Street analysts offering 12-month price targets for Ardent Health Partners, LLC, the average price target is $14.14, with a high forecast of $19.00, and a low forecast of $12.00.
The average price target represents a +50.11% change from the last price of $9.42.
Highest Price Target
$19.00
Average Price Target
$14.14
Lowest Price Target
$12.00
ARDT Analyst Ratings
Buy
Based on 12 analysts giving stock ratings to Ardent Health Partners, LLC in the past 3 months
EPS Estimates — ARDT
84%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $1.59
vs Est $1.21
▲ 23.7% off
2025
Actual $0.96
vs Est $1.05
▼ 9.2% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is declining. Analysts forecast meaningful EPS growth ahead.
Revenue Estimates — ARDT
99%
Analyst Accuracy
Accurate
2 years compared
Actual vs Estimate
2024
Actual $5.966B
vs Est $5.843B
▲ 2.1% off
2025
Actual $6.324B
vs Est $6.356B
▼ 0.5% off
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
